Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune Cell and Other Noncardiomyocyte Regulation of Cardiac Hypertrophy and Remodeling
Ryan A. Frieler, Richard M. Mortensen
Circulation (2015) Vol. 131, Iss. 11, pp. 1019-1030
Open Access | Times Cited: 305

Showing 1-25 of 305 citing articles:

Mechanisms of physiological and pathological cardiac hypertrophy
Michinari Nakamura, Junichi Sadoshima
Nature Reviews Cardiology (2018) Vol. 15, Iss. 7, pp. 387-407
Closed Access | Times Cited: 1260
Revisiting Cardiac Cellular Composition
Alexander R. Pinto, Alexei Ilinykh, Malina J. Ivey, et al.
Circulation Research (2016) Vol. 118, Iss. 3, pp. 400-409
Open Access | Times Cited: 1209
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Steven J. Forrester, George W. Booz, Curt D. Sigmund, et al.
Physiological Reviews (2018) Vol. 98, Iss. 3, pp. 1627-1738
Open Access | Times Cited: 885
Physiological and pathological cardiac hypertrophy
Ippei Shimizu, Tohru Minamino
Journal of Molecular and Cellular Cardiology (2016) Vol. 97, pp. 245-262
Closed Access | Times Cited: 776
Heart Failure in Type 2 Diabetes Mellitus
Helena Kenny, E. Dale Abel
Circulation Research (2019) Vol. 124, Iss. 1, pp. 121-141
Open Access | Times Cited: 536
Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment
Paula S. Azevedo, Bertha Furlan Polegato, Marcos Ferreira Minicucci, et al.
Arquivos Brasileiros de Cardiologia (2015)
Open Access | Times Cited: 426
Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities
Ilaria Russo, Nikolaos G. Frangogiannis
Journal of Molecular and Cellular Cardiology (2015) Vol. 90, pp. 84-93
Open Access | Times Cited: 399
Single-cell reconstruction of the adult human heart during heart failure and recovery reveals the cellular landscape underlying cardiac function
Li Wang, Yu Peng, Bingying Zhou, et al.
Nature Cell Biology (2020) Vol. 22, Iss. 1, pp. 108-119
Closed Access | Times Cited: 350
The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy
Stéphane Heymans, Urs Eriksson, Jukka Lehtonen, et al.
Journal of the American College of Cardiology (2016) Vol. 68, Iss. 21, pp. 2348-2364
Open Access | Times Cited: 314
Cardiac fibrosis: new insights into the pathogenesis
Zhen‐Guo Ma, Yu‐Pei Yuan, Hai‐Ming Wu, et al.
International Journal of Biological Sciences (2018) Vol. 14, Iss. 12, pp. 1645-1657
Open Access | Times Cited: 279
Role of Inflammation in Heart Failure
Lily F. Shirazi, Joe K. Bissett, Francesco Romeo, et al.
Current Atherosclerosis Reports (2017) Vol. 19, Iss. 6
Closed Access | Times Cited: 247
Targeted Ablation of Periostin-Expressing Activated Fibroblasts Prevents Adverse Cardiac Remodeling in Mice
Harmandeep Kaur, Mikito Takefuji, CW Ngai, et al.
Circulation Research (2016) Vol. 118, Iss. 12, pp. 1906-1917
Open Access | Times Cited: 231
Immune mechanisms in heart failure
Yingying Zhang, Johann Bauersachs, Harald F. Langer
European Journal of Heart Failure (2017) Vol. 19, Iss. 11, pp. 1379-1389
Open Access | Times Cited: 220
Cardiomyopathy in obesity, insulin resistance and diabetes
Michinari Nakamura, Junichi Sadoshima
The Journal of Physiology (2019) Vol. 598, Iss. 14, pp. 2977-2993
Open Access | Times Cited: 219
Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease
Stephanie Matt, Peter J. Gaskill
Journal of Neuroimmune Pharmacology (2019) Vol. 15, Iss. 1, pp. 114-164
Open Access | Times Cited: 212
An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy
Giacomo Frati, Leonardo Schirone, Isotta Chimenti, et al.
Cardiovascular Research (2017) Vol. 113, Iss. 4, pp. 378-388
Open Access | Times Cited: 203
A hypothesis for pathobiology and treatment of COVID‐19: The centrality of ACE1/ACE2 imbalance
Krishna Sriram, Paul A. Insel
British Journal of Pharmacology (2020) Vol. 177, Iss. 21, pp. 4825-4844
Open Access | Times Cited: 189
Single-Cell Reconstruction of Progression Trajectory Reveals Intervention Principles in Pathological Cardiac Hypertrophy
Zongna Ren, Yu Peng, Dandan Li, et al.
Circulation (2020) Vol. 141, Iss. 21, pp. 1704-1719
Open Access | Times Cited: 188
NFkappaB is a Key Player in the Crosstalk between Inflammation and Cardiovascular Diseases
Antonella Fiordelisi, Guido Iaccarino, Carmine Morisco, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 7, pp. 1599-1599
Open Access | Times Cited: 185
Mechanisms contributing to cardiac remodelling
Qingqing Wu, Yang Xiao, Yuan Yuan, et al.
Clinical Science (2017) Vol. 131, Iss. 18, pp. 2319-2345
Closed Access | Times Cited: 183
Vascular Senescence in Cardiovascular and Metabolic Diseases
Goro Katsuumi, Ippei Shimizu, Yohko Yoshida, et al.
Frontiers in Cardiovascular Medicine (2018) Vol. 5
Open Access | Times Cited: 173
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
Teresa Salvatore, Pia Clara Pafundi, Raffaele Galiero, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 107
Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction
Rebecca J. Woolley, Daan Ceelen, Wouter Ouwerkerk, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 6, pp. 983-991
Open Access | Times Cited: 105
Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential
Thomas G. Martin, Miranda A. Juarros, Leslie A. Leinwand
Nature Reviews Cardiology (2023) Vol. 20, Iss. 5, pp. 347-363
Open Access | Times Cited: 75
Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy
Brahmanaidu Parim, V. V. Sathibabu Uddandrao, Ganapathy Saravanan
Heart Failure Reviews (2018) Vol. 24, Iss. 2, pp. 279-299
Closed Access | Times Cited: 147
Page 1 - Next Page

Scroll to top